CARISOPRODOL COMPOUND Drug Patent Profile
✉ Email this page to a colleague
When do Carisoprodol Compound patents expire, and what generic alternatives are available?
Carisoprodol Compound is a drug marketed by Watson Labs and is included in one NDA.
The generic ingredient in CARISOPRODOL COMPOUND is aspirin; carisoprodol. There are twenty-two drug master file entries for this compound. Additional details are available on the aspirin; carisoprodol profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CARISOPRODOL COMPOUND?
- What are the global sales for CARISOPRODOL COMPOUND?
- What is Average Wholesale Price for CARISOPRODOL COMPOUND?
Summary for CARISOPRODOL COMPOUND
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | CARISOPRODOL COMPOUND at DailyMed |
US Patents and Regulatory Information for CARISOPRODOL COMPOUND
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Watson Labs | CARISOPRODOL COMPOUND | aspirin; carisoprodol | TABLET;ORAL | 088809-001 | Oct 3, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
